Rivabazumab
Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV[1].
Product Specifications
CAS Number
1627519-84-9
Product Name Alternative
KB001
UNSPSC
12352203
Target
Bacterial
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/rivabazumab.html
Purity
99
Solubility
10 mM in DMSO
Smiles
[Rivabazumab]
References & Citations
[1]Wenshe Ray LIU, et al. Protease switch for dual targets chimeric antigen receptor t cell therapy. WO2021087245.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-0837R-Biotin-TR 20 µL
Glutathione Reductase Polyclonal Antibody, Biotin Conjugated
Sign In for Pricing
View Details 
45401111 3x 1.0 µg
SPRY4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
HP210419 200 Reactions
NNT1 (CLCF1) Human qPCR Primer Pair (NM_013246)
Sign In for Pricing
View Details